Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information.

Umbilical cord blood transplantation has transformed the treatment options for patients with blood cancers and other ...

A Japanese study of more than 7,400 patients has identified a genetic mismatch that sharply increases the risk of severe acute graft-versus-host disease (GVHD) following umbilical cord blood ...

For more than six decades, biomarker-based newborn screening has played a pivotal role in reducing infant mortality and ...

Umbilical cord blood transplantation has transformed the treatment options for patients with blood cancers and other life-threatening hematological ...

Society / One key revelation in the wide correspondence of the late pedophile: the rich and powerful just aren’t all that ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...

Fragments of DNA from long-extinct human relatives still circulate in modern genomes, and in some cases they do more than ...

A recent review concluded that artificial intelligence (AI) is rapidly transforming the diagnosis and treatment of haematological malignancies by enhancing diagnostic accuracy and ...

Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst - POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 / IGC Pharma, Inc. ("IGC" or the " ...

GSK’s own proprietary platform is called Cogito Forge. It is not a standard AI search model, but one that uses ‘agents’ that ...

Infleqtion has been selected to advance to Phase 3 of the Q4Bio Challenge, a global program demonstrating quantum-enabled solutions for human health.